Home

Autism-Vaccine Cover-up Snowballs as Whistleblower’s Identity is Revealed—LATEST UPDATES

4 Comments

strip bannerlogo-new
August 26, 2014

Vaccine-Autism link whistleblower revealed

Rumors are swirling as the world learns of the government’s deception. Here’s what we know for sure.

William W. Thompson, PhD—an epidemiologist at the CDC’s National Center of Birth Defects and Development Disabilities who received his doctorate in biochemical engineering—has been revealed as the CDC whistleblower. Thompson broke a decade of silence over the government’s deliberate concealment of the link between the MMR vaccine (for measles, mumps, and rubella) and a dramatically increased risk of autism, particularly in African American boys.

Thompson is alleging criminal wrongdoing on the part of his supervisors, and has expressed deep regret about his role in helping the CDC hide data: “It’s the lowest point in checking vaccine 25my career, that I went along with that paper.”

Here is a quick timeline of the scandal:
•In February 2004, a study of the MMR vaccine was published in the journal Pediatrics by three CDC scientists working in the National Immunization Program; one of them was Dr. Thompson. The study, in which vaccine data was gathered on 2,583 children in metropolitan Atlanta born between 1986 and 1993, concluded that there were “no significant associations” between the age at which the vaccine is administered and the incidence of “developmental regression” such as autism. This study has been used for the past decade by the those seeking to say there is no link between autism and vaccines. It should be noted that Pediatrics receives financial support from vaccine makers through advertising and direct donations, according to a CBS News report.
•That same month, Dr. Thompson wrote to Dr. Julie Gerberding (then director of the CDC, now director of Merck’s vaccine division). In this letter he discusses his intention to present, at an Institute of Medicine meeting on vaccines and autism the following week, “several problematic results” that the Atlanta study had produced. More

Marijuana – Reefer Madness or Cure-all?

Leave a comment

bud

By Barbara H. Peterson

Farm Wars

December 20, 2009

Controversy surrounding the use of marijuana, whether it is for recreational or medical purposes, is heating up.

The first state to legalize marijuana for medical purposes, California leads the country in decriminalizing the sale and use of cannabis. Other states are considering the issue… Now, a new initiative that will allow local governments to oversee and regulate cultivation, distribution, and sales – and to determine how and how much cannabis can be bought and sold within area limits – will be on the November 2010 ballot. National advocates say that regardless of the vote – signature gathering went fast and easy, according to reports – a major corner has been turned in national acceptance of marijuana use. (CSMonitor)

The real question is, why should a harmless plant that anyone can grow at home elicit such controversy. Why does the government care? Why criminalize it in the first place, and then keep it under control by regulating it after determining that people are going to use it anyway? The answer might lie here: READ MORE…

The Pharmaceutical Industry’s Unpleasant Hand in Health and Food Bills

2 Comments

by Patrick Henning                                                 Tell a Friend 

Robert Pear wrote an astounding article in the NY Times on Genetech’s influence on the healthcare bill, writing talking points for both sides of the aisle.  He proved Anthony Sutton’s proposition – that those with power simply use the left and right divide to get what they want, even setting it up.

And that global elite seems to working now through the pharmaceutical industry and bankers to gain power.  Interestingly, it was the pharmaceutical and chemical giant, IG Farben, which destabilized Germany, put Hitler in, and was the primary support for the 3rd Reich.  And the Rockefellers, oilmen and bankers with a focus on eugenics (genetic engineering), had a half interest in IG Farben and IG Farben a half interest in Standard Oil. More

Newer Entries

%d bloggers like this: